AI Biomed PredictionsELTX – ELTX nears binary pancreatic cancer readout with breakout potential ScanScor Admin / April 21, 2026
AI Biomed PredictionsALLR – ALLR’s next rerating likely hinges on ovarian enrollment completion ScanScor Admin / April 21, 2026
AI Biomed PredictionsCING – May FDA decision could redefine Cingulate’s tiny-cap valuation ScanScor Admin / April 18, 2026
AI Biomed PredictionsNXTC – ASCO SIM0505 data could reignite tiny-float NXTC shares ScanScor Admin / April 18, 2026
AI Biomed PredictionsCVKD – Phase 3 clarity could revive battered microcap HIT story ScanScor Admin / April 17, 2026
AI Biomed PredictionsKROS – Keros faces make-or-break DMD launch window in Q2 ScanScor Admin / April 16, 2026
AI Biomed PredictionsMBRX – Mid-2026 AML unblinding could redefine tiny-cap MBRX valuation ScanScor Admin / April 16, 2026
AI Biomed PredictionsKRRO – Korro’s next AATD nomination may reignite platform-belief rally ScanScor Admin / April 15, 2026
AI Biomed PredictionsNRXP – Summer FDA Ketamine Decision Could Reawaken NRXP Speculation ScanScor Admin / April 13, 2026
AI Biomed PredictionsBIVI – BioVie’s next real test is the mid-2026 Parkinson’s readout ScanScor Admin / April 12, 2026
